For research use only. Not for therapeutic Use.
<span style="color:#000000;"><span style="font-size: 12px;"><font face="arial, helvetica, sans-serif">Ifenprodil Tartrate (CAS 23210-58-4) </font><span style="font-variant-ligatures: normal; orphans: 2; widows: 2;"><font face="arial, helvetica, sans-serif">is an antagonist of NR1A/NR2B subunit-containing NMDA receptors (IC</font><font face="Lato, Lucida Grande, Lucida Sans Unicode, Lucida Sans, Geneva, Verdana, sans-serif">50</font></span><span style="font-family: arial, helvetica, sans-serif; font-variant-ligatures: normal; orphans: 2; widows: 2;"> = 340 nM).</span><span style="font-family: arial, helvetica, sans-serif; font-variant-ligatures: normal; orphans: 2; widows: 2;">Ifenprodil inhibits infection of MDCK cells by H1N1 and H3N2 influenza isolates in vitro</span><span style="font-family: arial, helvetica, sans-serif; font-variant-ligatures: normal; orphans: 2; widows: 2;"> (EC</span><span style="font-variant-ligatures: normal; orphans: 2; widows: 2;"><font face="Lato, Lucida Grande, Lucida Sans Unicode, Lucida Sans, Geneva, Verdana, sans-serif">50</font></span><span style="font-family: arial, helvetica, sans-serif; font-variant-ligatures: normal; orphans: 2; widows: 2;">s = 7.2 and 12.1 µM, respectively).</span><span style="font-family: arial, helvetica, sans-serif; font-variant-ligatures: normal; orphans: 2; widows: 2;"> It increases the production of NGF, BDNF, and GDNF in primary mouse astrocytes when used at a concentration of 150 µM.</span><span style="font-family: arial, helvetica, sans-serif; font-variant-ligatures: normal; orphans: 2; widows: 2;"> Ifenprodil also reduces maximal electroshock seizures in mice (ED</span><span style="font-variant-ligatures: normal; orphans: 2; widows: 2;"><font face="Lato, Lucida Grande, Lucida Sans Unicode, Lucida Sans, Geneva, Verdana, sans-serif">50</font></span><span style="font-family: arial, helvetica, sans-serif; font-variant-ligatures: normal; orphans: 2; widows: 2;">s = 16 and 7 mg/kg, respectively).</span></span></span>
Catalog Number | A000836 |
CAS Number | 23210-58-4 |
Synonyms | NA |
Molecular Formula | C21H27NO2 • 1/2C4H6O6 |
Purity | ≥95% |
Target | Neuronal Signaling |
Solubility | Soluble in DMSO > 10 mM |
Storage | Store at -20C |
IUPAC Name | 4-[2-(4-benzylpiperidin-1-yl)-1-hydroxypropyl]phenol;(2R,3R)-2,3-dihydroxybutanedioic acid |
InChI | InChI=1S/2C21H27NO2.C4H6O6/c2*1-16(21(24)19-7-9-20(23)10-8-19)22-13-11-18(12-14-22)15-17-5-3-2-4-6-17;5-1(3(7)8)2(6)4(9)10/h2*2-10,16,18,21,23-24H,11-15H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t;;1-,2-/m..1/s1 |
InChIKey | DMPRDSPPYMZQBT-CEAXSRTFSA-N |
SMILES | CC(C(C1=CC=C(C=C1)O)O)N2CCC(CC2)CC3=CC=CC=C3.CC(C(C1=CC=C(C=C1)O)O)N2CCC(CC2)CC3=CC=CC=C3.C(C(C(=O)O)O)(C(=O)O)O |
Reference | <span style="color:#000000;"><span style="font-family:arial,helvetica,sans-serif;"><span style="font-size:12px;">1.<span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">Williams, Keith. "Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors." </span><i style="font-family: Arial, sans-serif; font-size: 13px; font-variant-ligatures: normal; orphans: 2; widows: 2;">Molecular pharmacology</i><span style="font-variant-ligatures: normal; orphans: 2; widows: 2;"> 44.4 (1993): 851-859.<br /> |